One in ten patients with nonvalvular atrial fibrillation (NVAF) prescribed direct oral anticoagulants (DOACs) failed to take their first prescription, according to a new study published in the Journal of Managed Care + Specialty Pharmacy.
DOACs are commonly prescribed to limit the risk of stroke among NVAF patients, the study's authors explained, and nonadherence can have grave consequences for those individuals. However, they added, few studies have examined nonadherence rates found in real-world data.
The team tracked data from 12,257 patients with NVAF who were treated from January 2009 to December 2015 in Spain. Fifty-three percent of the patients were men, and the mean patient age was 74.6 years old.
Overall, primary nonadherence, defined as never collecting their first prescription, was seen in 10.4% of those patients.
"many" - Google News
October 26, 2021 at 04:14AM
https://ift.tt/2ZjeNhB
Many nonvalvular AFib patients skip DOAC therapy altogether - Cardiovascular Business
"many" - Google News
https://ift.tt/2OYUfnl
https://ift.tt/3f9EULr
No comments:
Post a Comment